Alzheimer's disease is a major public health problem for the United States. Up to 4 million older Americans currently suffer with Alzheimer's disease, and up to 12 million are expected to by the year 2020. Rational design of effective therapeutics will require a detailed understanding of the pathophysiology of Alzheimer's disease. The long-term objective of this project is to understand how different isoforms of apolipoprotein E specifically modify the distribution and amount of neurotoxic lipid peroxidation products in the brain, thereby contributing to the stratification of risk for Alzheimer's disease with apolipoprotein E genotype.
The specific aims of this application are: 1) to determine the mechanisms of apoE isoform-specific distribution of human native central nervous system lipoproteins by quantifying cell surface receptor binding, internalization, and degradation of human central nervous system lipoproteins in cultured neurons and astrocytes; 2) to determine the pathogenicity of apolipoprotein E isoform-directed delivery of oxidized central nervous system lipoproteins by purifying oxidized central nervous system lipoproteins from Alzheimer's disease patients or oxidizing ex vivo central nervous system lipoproteins from control subjects and quantifying their neurodegenerative and cytoskeletal damaging effects in neurons and astrocytes; and 3) to quantify regional brain lipid peroxidation in vivo and examine its relationship to differences in the apolipoprotein E gene by quantifying brain regional F2-isoprostanes and F4-neuroprostanes in Alzheimer's disease patients with different apolipoprotein E genotypes and in homozygous apolipoprotein E deficient mice. This new information will aid in laying the foundation for designing rational therapeutic approaches to ameliorate brain oxidative damage in Alzheimer's disease.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
7R01AG016835-05
Application #
6629843
Study Section
Special Emphasis Panel (ZRG1-BDCN-3 (01))
Program Officer
Snyder, Stephen D
Project Start
1999-05-01
Project End
2004-04-30
Budget Start
2002-09-01
Budget End
2003-04-30
Support Year
5
Fiscal Year
2002
Total Cost
$266,555
Indirect Cost
Name
University of Washington
Department
Pathology
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Taylor, Alan W; Bruno, Richard S; Frei, Balz et al. (2006) Benefits of prolonged gradient separation for high-performance liquid chromatography-tandem mass spectrometry quantitation of plasma total 15-series F-isoprostanes. Anal Biochem 350:41-51
Bruno, Richard S; Leonard, Scott W; Atkinson, Jeffery et al. (2006) Faster plasma vitamin E disappearance in smokers is normalized by vitamin C supplementation. Free Radic Biol Med 40:689-97
Fishel, Mark A; Watson, G Stennis; Montine, Thomas J et al. (2005) Hyperinsulinemia provokes synchronous increases in central inflammation and beta-amyloid in normal adults. Arch Neurol 62:1539-44
Zhang, Jing; Goodlett, Dave R; Quinn, Joseph F et al. (2005) Quantitative proteomics of cerebrospinal fluid from patients with Alzheimer disease. J Alzheimers Dis 7:125-33; discussion 173-80
Woltjer, Randall L; Nghiem, William; Maezawa, Izumi et al. (2005) Role of glutathione in intracellular amyloid-alpha precursor protein/carboxy-terminal fragment aggregation and associated cytotoxicity. J Neurochem 93:1047-56
Neely, M Diana; Boutte, A; Milatovic, D et al. (2005) Mechanisms of 4-hydroxynonenal-induced neuronal microtubule dysfunction. Brain Res 1037:90-8
Bruno, Richard S; Ramakrishnan, Rajasekhar; Montine, Thomas J et al. (2005) {alpha}-Tocopherol disappearance is faster in cigarette smokers and is inversely related to their ascorbic acid status. Am J Clin Nutr 81:95-103
Montine, Thomas J; Montine, Kathleen S; McMahan, Wendy et al. (2005) F2-isoprostanes in Alzheimer and other neurodegenerative diseases. Antioxid Redox Signal 7:269-75
Maezawa, Izumi; Jin, Lee-Way; Woltjer, Randall L et al. (2004) Apolipoprotein E isoforms and apolipoprotein AI protect from amyloid precursor protein carboxy terminal fragment-associated cytotoxicity. J Neurochem 91:1312-21
Shie, Feng-Shiun; Neely, M Diana; Maezawa, Izumi et al. (2004) Oxidized low-density lipoprotein is present in astrocytes surrounding cerebral infarcts and stimulates astrocyte interleukin-6 secretion. Am J Pathol 164:1173-81

Showing the most recent 10 out of 43 publications